Effect of angiotensin converting enzyme inhibitor on plasma von Willebrand factor level in patients with coronary artery disease

被引：1

作者：

Hojo, Y ^{[1
]}

Ikeda, U ^{[1
]}

Shimada, K ^{[1
]}

机构：

[1] Jichi Med Sch, Dept Cardiol, Minami Kawachi, Tochigi 3290498, Japan

来源：

CARDIOVASCULAR DRUGS AND THERAPY | 2001年 / 15卷 / 01期

关键词：

angiotensin II; atherosclerosis; von Willebrand factor;

D O I：

10.1023/A:1011123204697

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：91 / 92

页数：2

共 12 条

[1] Elevation of von Willebrand factor levels in patients with IgA nephropathy: Effect of ACE inhibition [J].

Hernandez, E ;

Toledo, T ;

Alamo, C ;

Mon, C ;

Rodicio, JL ;

Praga, M .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (03) :397-403

[2] Inhibition of angiotensin converting enzyme cannot prevent increases in angiotensin II production in coronary circulation [J].

Hojo, Y ;

Ikeda, U ;

Katsuki, T ;

Mizuno, O ;

Fujikawa, H ;

Shimada, K .

HEART, 2000, 83 (05) :574-576

[3]

JAGER A, 1999, ARTERIOSCLER THROMB, V19, P3017

[4]

JANSSON JH, 1991, BRIT HEART J, V66, P351

[5] Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris [J].

JuhanVague, I ;

Pyke, SDM ;

Alessi, MC ;

Jespersen, J ;

Haverkate, F ;

Thompson, SG .

CIRCULATION, 1996, 94 (09) :2057-2063

[6] Lipid-lowering therapy corrects endothelial cell dysfunction in a short time but does not affect hypercoagulable state even after long-term use in hyperlipidemic patients [J].

Kario, K ;

Matsuo, T ;

Hoshide, S ;

Kobayashi, H ;

Sakata, T ;

Mizuno, O ;

Mitsuhashi, T ;

Ikeda, U ;

Miyata, T ;

Shimada, K .

BLOOD COAGULATION & FIBRINOLYSIS, 1999, 10 (05) :269-276

[7] Bradykinin-induced vasodilation of human coronary arteries in vivo: Role of nitric oxide and angiotensin-converting enzyme [J].

Kuga, T ;

Mohri, M ;

Egashira, K ;

Hirakawa, Y ;

Tagawa, T ;

Shimokawa, H ;

Takeshita, A .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (01) :108-112

[8] Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease - The TREND (Trial on Reversing ENdothelial Dysfunction) study [J].

Mancini, GBJ ;

Henry, GC ;

Macaya, C ;

ONeill, BJ ;

Pucillo, AL ;

Carere, RG ;

Wargovich, TJ ;

Mudra, H ;

Luscher, TF ;

Klibaner, MI ;

Haber, HE ;

Uprichard, ACG ;

Pepine, CJ ;

Pitt, B .

CIRCULATION, 1996, 94 (03) :258-265

[9] von Willebrand factor - A marker of endothelial damage? [J].

Mannucci, PM .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (09) :1359-1362

[10] Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus [J].

ODriscoll, G ;

Green, D ;

Rankin, J ;

Stanton, K ;

Taylor, R .

JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (03) :678-684

← 1 2 →